- Home
- CNTB vs NB Comparison
CNTB vs NB Comparison
Compare CNTB & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- NB
- Stock Information
- Founded
- CNTB 2012
- NB 1987
- Country
- CNTB United States
- NB United States
- Employees
- CNTB N/A
- NB N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- CNTB Health Care
- NB Basic Materials
- Exchange
- CNTB Nasdaq
- NB Nasdaq
- Market Cap
- CNTB 65.5M
- NB 56.9M
- IPO Year
- CNTB 2021
- NB N/A
- Fundamental
- Price
- CNTB $1.06
- NB $1.41
- Analyst Decision
- CNTB Strong Buy
- NB Strong Buy
- Analyst Count
- CNTB 1
- NB 1
- Target Price
- CNTB $8.00
- NB $8.50
- AVG Volume (30 Days)
- CNTB 31.2K
- NB 183.0K
- Earning Date
- CNTB 09-05-2024
- NB 02-11-2025
- Dividend Yield
- CNTB N/A
- NB N/A
- EPS Growth
- CNTB N/A
- NB N/A
- EPS
- CNTB N/A
- NB N/A
- Revenue
- CNTB $24,116,000.00
- NB N/A
- Revenue This Year
- CNTB N/A
- NB N/A
- Revenue Next Year
- CNTB $63.90
- NB N/A
- P/E Ratio
- CNTB N/A
- NB N/A
- Revenue Growth
- CNTB N/A
- NB N/A
- 52 Week Low
- CNTB $0.77
- NB $1.27
- 52 Week High
- CNTB $2.66
- NB $4.00
- Technical
- Relative Strength Index (RSI)
- CNTB 46.58
- NB 47.42
- Support Level
- CNTB $1.04
- NB $1.36
- Resistance Level
- CNTB $1.23
- NB $1.74
- Average True Range (ATR)
- CNTB 0.10
- NB 0.12
- MACD
- CNTB 0.01
- NB 0.01
- Stochastic Oscillator
- CNTB 42.37
- NB 30.95
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.